BamSEC and AlphaSense Join Forces
Learn More

Qualigen Therapeutics Inc.

NASDAQ: QLGN    
Share price (1/8/25): $4.17    
Market cap (1/8/25): $3.071 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 17 pages Qualigen Therapeutics, Inc. Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series A-2 Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.4
from 8-K 8 pages Exchange Agreement
12/34/56
EX-3.3
from 8-K 16 pages Registration Rights Agreement
12/34/56
EX-3.2
from 8-K 15 pages Terms of Series A-2 Preferred Stock
12/34/56
EX-3.1
from 8-K 27 pages Securities Purchase Agreement
12/34/56
EX-3.1
from 8-K 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 2 pages Qualigen Therapeutics, Inc. Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.8
from 10-Q 12 pages Amended and Restated Bylaws of Qualigen Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.1
from 8-K 12 pages Amended and Restated Bylaws of Qualigen Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.1
from 8-K 12 pages Amended and Restated Bylaws of Qualigen Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.6
from 8-K 23 pages Qualigen, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Alpha Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.5
from 8-K 12 pages Amended and Restated Bylaws of Qualigen Therapeutics, Inc. Article 1 Offices
12/34/56
EX-3.4
from 8-K 2 pages Ritter Pharmaceuticals, Inc. Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.3
from 8-K 2 pages Certificate of Merger of Rpg28 Merger Sub, Inc. (A Delaware Corporation) With and Into Qualigen, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 22 pages Ritter Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Alpha Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.8
from S-4/A 17 pages Ritter Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Alpha Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.8
from S-4/A 17 pages Ritter Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Alpha Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.8
from S-4/A 23 pages Ritter Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series Alpha Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.2
from 10-Q 19 pages Ritter Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56